Skip to main content
Top
Published in: Clinical and Translational Oncology 9/2023

Open Access 09-08-2023 | SCLC | Correction

Correction to: SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)

Authors: Rosario García-Campelo, Ivana Sullivan, Edurne Arriola, Amelia Insa, Oscar Juan Vidal, Patricia Cruz-Castellanos, Teresa Morán, Noemí Reguart, Jon Zugazagoitia, Manuel Dómine

Published in: Clinical and Translational Oncology | Issue 9/2023

Login to get access

Excerpt

Correction to: Clinical and Translational Oncology https://doi.org/10.1007/s12094-023-03216-3
Metadata
Title
Correction to: SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)
Authors
Rosario García-Campelo
Ivana Sullivan
Edurne Arriola
Amelia Insa
Oscar Juan Vidal
Patricia Cruz-Castellanos
Teresa Morán
Noemí Reguart
Jon Zugazagoitia
Manuel Dómine
Publication date
09-08-2023
Publisher
Springer International Publishing
Keywords
SCLC
SCLC
Published in
Clinical and Translational Oncology / Issue 9/2023
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-023-03290-7

Other articles of this Issue 9/2023

Clinical and Translational Oncology 9/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine